Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Is mood chemistry?

Castrén E.

Nat Rev Neurosci. 2005 Mar;6(3):241-6. Review.

PMID:
15738959
2.

Brain, networks, depression, and more.

Leistedt SJ, Linkowski P.

Eur Neuropsychopharmacol. 2013 Jan;23(1):55-62. doi: 10.1016/j.euroneuro.2012.10.011. Epub 2012 Nov 13. Review.

PMID:
23154052
3.

A model for the involvement of neural cell adhesion molecules in stress-related mood disorders.

Sandi C, Bisaz R.

Neuroendocrinology. 2007;85(3):158-76. Epub 2007 Apr 3. Review.

PMID:
17409734
4.

Antidepressant drugs and cytokines in mood disorders.

Nishida A, Hisaoka K, Zensho H, Uchitomi Y, Morinobu S, Yamawaki S.

Int Immunopharmacol. 2002 Nov;2(12):1619-26. Review.

PMID:
12469936
5.

Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug development.

Benedetti F, Smeraldi E.

Curr Pharm Des. 2009;15(22):2637-49. Review.

PMID:
19689334
6.

Role of neurotrophic factors in depression.

Castrén E, Võikar V, Rantamäki T.

Curr Opin Pharmacol. 2007 Feb;7(1):18-21. Epub 2006 Oct 17. Review.

PMID:
17049922
7.

Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.

Hosokawa T, Momose T, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):243-50. doi: 10.1016/j.pnpbp.2008.11.014. Epub 2008 Dec 3.

PMID:
19100808
8.

Mood disorders: treatment-induced changes in brain neurochemistry and structure.

Glitz DA, Manji HK, Moore GJ.

Semin Clin Neuropsychiatry. 2002 Oct;7(4):269-80. Review.

PMID:
12382209
9.

Rats selectively-bred for behavior related to affective disorders: proclivity for intake of alcohol and drugs of abuse, and measures of brain monoamines.

Weiss JM, West CH, Emery MS, Bonsall RW, Moore JP, Boss-Williams KA.

Biochem Pharmacol. 2008 Jan 1;75(1):134-59. Epub 2007 Oct 6. Review.

PMID:
18053966
10.

New insights into the mechanisms of antidepressant therapy.

Schloss P, Henn FA.

Pharmacol Ther. 2004 Apr;102(1):47-60. Review.

PMID:
15056498
11.

Metabotropic glutamate receptors in the control of mood disorders.

Witkin JM, Marek GJ, Johnson BG, Schoepp DD.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100. Review.

PMID:
17430147
13.

In vivo neurochemical monitoring and the study of behaviour.

Fillenz M.

Neurosci Biobehav Rev. 2005;29(6):949-62. Review.

PMID:
15963566
14.

Postpartum mood disorders may be related to a decreased insulin level after delivery.

Chen TH, Lan TH, Yang CY, Juang KD.

Med Hypotheses. 2006;66(4):820-3.

PMID:
16321476
15.

Neurotrophins in depression and antidepressant effects.

Castrén E, Rantamäki T.

Novartis Found Symp. 2008;289:43-52; discussion 53-9, 87-93. Review.

PMID:
18497094
16.

In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review.

Capizzano AA, Jorge RE, Acion LC, Robinson RG.

J Magn Reson Imaging. 2007 Dec;26(6):1378-89. Review.

PMID:
17968885
17.

Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

CNS Drugs. 2006;20(8):633-54. Review.

PMID:
16863269
18.

To sleep--perchance to dream ... of affective disorders.

Stoline AM.

Am J Psychiatry. 1996 Jan;153(1):134-5. No abstract available.

PMID:
8540576
19.

Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.

Kozisek ME, Middlemas D, Bylund DB.

Pharmacol Ther. 2008 Jan;117(1):30-51. Epub 2007 Aug 15. Review.

PMID:
17949819
20.

Brain temperature may influence mood: a hypothesis.

Salerian AJ, Saleri NG, Salerian JA.

Med Hypotheses. 2008;70(3):497-500. Epub 2007 Oct 22.

PMID:
17951014
Items per page

Supplemental Content

Write to the Help Desk